BioCentury | Nov 2, 2009
Company News

Ligand, Metabasis deal

...MB07133 ; 60% of any net proceeds from any disposition of Metabasis' equity interest in PeriCor Therapeutics Inc....
BioCentury | May 18, 2009
Clinical News

Acadesine: Phase III started

...and commercialize IV acadesine from PeriCor under a 2007 deal (see BioCentury, July 23, 2007). PeriCor Therapeutics Inc....
BioCentury | Feb 18, 2008
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: K. Tucker Andersen Resigned: Larry Pickering WIR Staff...
BioCentury | Jul 23, 2007
Company News

PeriCor, Schering-Plough deal

...SGP will receive an exclusive worldwide license to develop and commercialize PeriCor's IV acadesine. The adenosine...
...ischemia/reperfusion injury. Financial terms were not disclosed. The deal is expected to close this quarter. PeriCor Therapeutics Inc....
BioCentury | Dec 11, 2006
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: Larry Pickering, healthcare industry partner at Avista Capital Holdings L.P. WIR Staff...
BioCentury | Dec 11, 2006
Company News

PeriCor management update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Deceased: Ross Dixon, VP of pharmaceutical development WIR Staff Cardiovascular...
BioCentury | Oct 2, 2006
Clinical News

PeriCor preclinical data

...coverage and penetration. Additionally, the direct thrombin inhibitor retained its activity by binding to thrombin. PeriCor Therapeutics Inc....
BioCentury | Jul 10, 2006
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: Robert Engler, a professor of medicine at the University of California at San Diego WIR Staff...
BioCentury | Mar 20, 2006
Clinical News

Acadesine cardiovascular data

...77% vs. placebo. Data were presented at the American College of Cardiology meeting in Atlanta. PeriCor Therapeutics Inc....
Items per page:
1 - 9 of 9
BioCentury | Nov 2, 2009
Company News

Ligand, Metabasis deal

...MB07133 ; 60% of any net proceeds from any disposition of Metabasis' equity interest in PeriCor Therapeutics Inc....
BioCentury | May 18, 2009
Clinical News

Acadesine: Phase III started

...and commercialize IV acadesine from PeriCor under a 2007 deal (see BioCentury, July 23, 2007). PeriCor Therapeutics Inc....
BioCentury | Feb 18, 2008
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: K. Tucker Andersen Resigned: Larry Pickering WIR Staff...
BioCentury | Jul 23, 2007
Company News

PeriCor, Schering-Plough deal

...SGP will receive an exclusive worldwide license to develop and commercialize PeriCor's IV acadesine. The adenosine...
...ischemia/reperfusion injury. Financial terms were not disclosed. The deal is expected to close this quarter. PeriCor Therapeutics Inc....
BioCentury | Dec 11, 2006
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: Larry Pickering, healthcare industry partner at Avista Capital Holdings L.P. WIR Staff...
BioCentury | Dec 11, 2006
Company News

PeriCor management update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Deceased: Ross Dixon, VP of pharmaceutical development WIR Staff Cardiovascular...
BioCentury | Oct 2, 2006
Clinical News

PeriCor preclinical data

...coverage and penetration. Additionally, the direct thrombin inhibitor retained its activity by binding to thrombin. PeriCor Therapeutics Inc....
BioCentury | Jul 10, 2006
Company News

PeriCor board of directors update

PeriCor Therapeutics Inc. , New York, N.Y. Business: Cardiovascular Appointed: Robert Engler, a professor of medicine at the University of California at San Diego WIR Staff...
BioCentury | Mar 20, 2006
Clinical News

Acadesine cardiovascular data

...77% vs. placebo. Data were presented at the American College of Cardiology meeting in Atlanta. PeriCor Therapeutics Inc....
Items per page:
1 - 9 of 9